Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study
| Autor: | Kirby, Joslyn S., Okun, Martin M., Alavi, Afsaneh, Bechara, Falk G., Zouboulis, Christos C., Brown, Kurt, Santos, Leandro L., Wang, Annie, Bibeau, Kristen B., Kimball, Alexa B., Porter, Martina L. |
|---|---|
| Zdroj: | In Journal of the American Academy of Dermatology March 2024 90(3):521-529 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect